NCT07912268
Study of SIM0518 in Participants With ALK-Positive or ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Secondary (16)
Show 11 moreShow less
Arms and interventions
SIM0518 Capsule, Use as specified in the Protocol
SIM0518 Capsuleand Midazolam Oral Solution ,Use as Specified in the Protocol
SIM0518 Capsule and Bupropion Hydrochloride Tablets ,Use as Specified in the Protocol
SIM0518 Capsuleand Repaglinide Tablets ,Use as Specified in the Protocol
SIM0518 Capsule, and Tolbutamid Tablets,Use as Specified in the Protocol
SIM0518 Capsule and Fexofenadine Hydrochloride Tablets ,Use as Specified in the Protocol
SIM0518 Capsule and Rosuvastatin Calcium Tablets ,Use as Specified in the Protocol
Drugs: SIM0518, SIM0518+Bupropion, SIM0518+Midazolam, SIM0518+Repaglinide, SIM0518+Tolbutamide, SIM0518+Fexofenadine, SIM0518+ Rosuvastatin Calcium
Sites
8 sites in 1 country